Borregaard ASA

BRG · OL · Basic Materials / Specialty Chemicals

155.60NOK-1.20 (-0.77%)

Price History

Full chart

Market Stats

Previous Close156.80

Open156.80

Day Range154.60 – 156.80

52-Week Range137.60 – 195.03

Volume57.68K

Market Cap15.27B

P/E (TTM)90.65

Forward P/E14.64

EPS1.69

Dividend Yield3.15%

Beta0.57

50-Day Avg154.68

200-Day Avg164.45

About

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.

Company Details

SectorBasic Materials
IndustrySpecialty Chemicals
CEOMr. Tom Erik Foss-Jacobsen
Employees1.19K
HeadquartersPO Box 162, Sarpsborg, Norway, 1701, Norway
Websitehttps://www.borregaard.com

Leadership

Mr. Tom Erik Foss-JacobsenChief Executive Officer · b. 1969
Mr. Per Bjarne LyngstadChief Financial Officer · b. 1961
Mr. Dag Arthur AasbøSenior Vice President of Public Affairs & Sustainability · b. 1961
Ms. Kari StrandeSenior VP of Human Resources · b. 1962
Mr. Gisle Løhre JohansenExecutive Vice President of Speciality Cellulose & Fine Chemicals · b. 1959
Mr. Ole Gunnar JakobsenExecutive VP of Manufacturing & Technology · b. 1969
Ms. Kristin MisundSenior Vice President of R&D and Business Development · b. 1965
Ms. Liv LongvaSenior Vice President of Procurement & Strategic Sourcing · b. 1969
Mr. Knut-Harald BakkeExecutive Vice President of BioSolutions
Ms. Guro Elise FredheimChief Technology Officer

Financials

Income Statement

Currency: NOK	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	3.38B	3.46B	3.85B	3.94B	4.00B	3.94B	4.16B	4.49B	4.62B	4.79B	5.06B	5.33B	5.80B	6.88B	7.02B	7.50B	7.58B
Growth (%)	-	+2.34%	+11.36%	+2.26%	+1.42%	-1.45%	+5.71%	+7.88%	+2.80%	+3.62%	+5.81%	+5.23%	+8.95%	+18.54%	+2.08%	+6.81%	+1.04%
Cost of Revenue	1.53B	1.52B	1.60B	1.67B	1.66B	1.61B	1.67B	1.69B	1.68B	1.84B	1.89B	1.92B	2.15B	2.63B	2.54B	2.73B	2.66B
Gross Profit	1.85B	1.94B	2.25B	2.27B	2.34B	2.33B	2.49B	2.81B	2.94B	2.94B	3.17B	3.41B	3.65B	4.25B	4.48B	4.77B	4.92B
Gross Margin	54.70%	55.97%	58.35%	57.73%	58.49%	59.03%	59.87%	62.47%	63.60%	61.48%	62.67%	63.95%	62.93%	61.81%	63.77%	63.58%	64.92%
Operating Expense	1.60B	1.63B	1.72B	1.81B	1.82B	1.87B	1.96B	2.05B	2.20B	2.37B	2.62B	2.84B	2.70B	3.07B	3.19B	3.49B	3.63B
Operating Income	247.00M	305.00M	530.00M	468.00M	513.00M	456.00M	533.00M	756.00M	736.00M	576.00M	558.00M	568.00M	952.00M	1.19B	1.29B	1.28B	1.29B
Operating Margin	7.30%	8.81%	13.75%	11.88%	12.83%	11.58%	12.80%	16.83%	15.94%	12.04%	11.02%	10.66%	16.40%	17.24%	18.38%	17.10%	16.98%
EBITDA	485.00M	520.00M	744.00M	712.00M	733.00M	764.00M	802.00M	1.03B	1.05B	926.00M	976.00M	1.05B	1.35B	1.68B	1.78B	1.86B	1.62B
EBITDA Margin	14.34%	15.02%	19.30%	18.07%	18.34%	19.40%	19.26%	22.95%	22.82%	19.35%	19.28%	19.80%	23.34%	24.42%	25.41%	24.81%	21.33%
Net Income	139.00M	180.00M	317.00M	273.00M	335.00M	334.00M	386.00M	555.00M	566.00M	476.00M	417.00M	436.00M	692.00M	892.00M	870.00M	823.00M	620.00M
Net Income Margin	4.11%	5.20%	8.23%	6.93%	8.38%	8.48%	9.27%	12.36%	12.26%	9.95%	8.24%	8.18%	11.92%	12.96%	12.39%	10.97%	8.18%
R&D	-	-	-	-	-	-	-	107.00M	133.00M	117.00M	114.00M	100.00M	85.00M	97.00M	99.00M	121.00M	-
R&D as % of Total Revenue	-	-	-	-	-	-	-	2.38%	2.88%	2.45%	2.25%	1.88%	1.46%	1.41%	1.41%	1.61%	-
Interest Expense	58.00M	54.00M	84.00M	71.00M	45.00M	90.00M	30.00M	29.00M	29.00M	37.00M	87.00M	82.00M	72.00M	90.00M	178.00M	199.00M	162.00M
Interest Expense % of Total Revenue	1.71%	1.56%	2.18%	1.80%	1.13%	2.28%	0.72%	0.65%	0.63%	0.77%	1.72%	1.54%	1.24%	1.31%	2.53%	2.65%	2.14%

Balance Sheet

Currency: NOK	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	3.43B	3.56B	3.70B	3.54B	3.44B	3.75B	4.17B	4.67B	5.33B	5.95B	6.74B	7.00B	7.17B	8.11B	9.12B	9.58B	9.67B
Total Liabilities	2.08B	2.55B	2.58B	1.81B	1.59B	1.80B	2.11B	1.96B	2.34B	2.63B	3.28B	3.23B	2.86B	3.67B	4.22B	4.49B	3.79B
Total Equity	1.33B	998.00M	1.11B	1.73B	1.85B	1.94B	2.06B	2.68B	2.89B	3.12B	3.31B	3.67B	4.22B	4.39B	4.86B	5.04B	5.85B
Cash	340.00M	427.00M	496.00M	155.00M	58.00M	168.00M	169.00M	265.00M	180.00M	86.00M	147.00M	205.00M	121.00M	234.00M	469.00M	82.00M	91.00M
Total Debt	1.42B	1.89B	1.81B	1.01B	780.00M	792.00M	811.00M	586.00M	1.03B	1.39B	2.03B	2.00B	1.54B	2.07B	2.26B	2.32B	-
Net Debt	1.08B	1.46B	1.31B	851.00M	722.00M	624.00M	642.00M	321.00M	846.00M	1.30B	1.88B	1.80B	1.42B	1.84B	1.79B	2.24B	2.09B

Cash Flow

Currency: NOK	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	504.00M	452.00M	536.00M	551.00M	540.00M	600.00M	563.00M	1.08B	780.00M	558.00M	697.00M	886.00M	1.43B	735.00M	1.56B	1.07B	1.36B
Investing Cash Flow	-133.00M	-210.00M	-247.00M	-386.00M	-290.00M	-311.00M	-425.00M	-617.00M	-958.00M	-749.00M	-554.00M	-489.00M	-692.00M	-455.00M	-829.00M	-842.00M	-
Financing Cash Flow	-465.00M	-148.00M	-214.00M	-491.00M	-362.00M	-206.00M	-182.00M	-365.00M	97.00M	100.00M	-149.00M	-381.00M	-837.00M	-202.00M	-415.00M	-679.00M	-
Capital Expenditure	128.00M	205.00M	251.00M	388.00M	292.00M	313.00M	430.00M	622.00M	968.00M	762.00M	583.00M	503.00M	556.00M	464.00M	667.00M	711.00M	793.00M
Free Cash Flow	376.00M	247.00M	285.00M	163.00M	248.00M	287.00M	133.00M	459.00M	-188.00M	-204.00M	114.00M	383.00M	875.00M	271.00M	896.00M	357.00M	563.00M
Dividends Paid	214.00M	609.00M	149.00M	310.00M	100.00M	109.00M	124.00M	149.00M	349.00M	199.00M	224.00M	229.00M	249.00M	499.00M	324.00M	374.00M	424.00M
FCF to OCF	74.60%	54.65%	53.17%	29.58%	45.93%	47.83%	23.62%	42.46%	-24.10%	-36.56%	16.36%	43.23%	61.15%	36.87%	57.33%	33.43%	41.52%
Dividend Paid to FCF	56.91%	246.56%	52.28%	190.18%	40.32%	37.98%	93.23%	32.46%	-185.64%	-97.55%	196.49%	59.79%	28.46%	184.13%	36.16%	104.76%	75.31%

Earnings

Report Date	Nov 28, 2012	Feb 6, 2013	Apr 30, 2013	Jul 17, 2013	Oct 29, 2013	Feb 5, 2014	Apr 29, 2014	Jul 16, 2014	Oct 22, 2014	Feb 4, 2015	Apr 28, 2015	Jul 15, 2015	Oct 21, 2015	Feb 3, 2016	Apr 27, 2016	Jul 18, 2016	Oct 21, 2016	Feb 10, 2017	May 3, 2017	Jul 18, 2017	Oct 24, 2017	Feb 2, 2018	Apr 26, 2018	Jul 17, 2018	Oct 23, 2018	Jan 31, 2019	May 3, 2019	Jul 16, 2019	Oct 18, 2019	Feb 5, 2020	Apr 29, 2020	Jul 16, 2020	Oct 20, 2020	Feb 2, 2021	Apr 28, 2021	Jul 14, 2021	Oct 21, 2021	Feb 2, 2022	May 3, 2022	Jul 14, 2022	Oct 21, 2022	Feb 1, 2023	May 3, 2023	Jul 17, 2023	Oct 24, 2023	Jan 31, 2024	Apr 24, 2024	Jul 16, 2024	Oct 30, 2024	Jan 29, 2025	Apr 30, 2025	Jul 16, 2025	Oct 22, 2025	Feb 4, 2026	Apr 29, 2026	Jul 15, 2026	Oct 28, 2026
EPS Estimate	-	0.49	0.68	0.97	0.94	0.63	0.59	1.09	0.90	0.94	0.88	1.02	1.33	0.65	0.94	1.42	1.41	1.08	1.43	1.62	1.60	0.71	1.16	1.40	1.30	0.50	1.30	1.39	1.32	0.80	1.62	0.89	1.25	0.71	1.29	1.63	1.79	1.35	1.78	2.39	2.20	1.65	2.29	2.27	2.28	0.97	2.16	2.63	2.47	1.50	2.40	2.62	2.29	1.76	2.47	1.60	2.33
EPS Actual	0.92	0.42	0.65	0.88	1.20	0.62	0.65	0.91	1.10	0.68	0.74	0.92	1.12	1.08	1.21	1.54	1.57	1.23	1.48	1.81	1.47	0.99	1.37	1.32	1.27	0.80	1.26	1.22	1.31	0.38	1.02	1.01	1.12	1.21	1.47	2.34	2.12	1.02	2.17	2.52	2.40	1.85	2.31	2.84	2.37	1.19	2.00	2.45	2.50	1.30	2.52	2.56	1.96	1.64	1.82	2.35	-
Surprise	-	-14.29%	-4.41%	-9.28%	27.66%	-1.59%	10.17%	-16.51%	22.22%	-27.66%	-15.91%	-9.80%	-15.79%	66.15%	28.72%	8.45%	11.35%	13.89%	3.50%	11.73%	-8.13%	39.44%	18.10%	-5.71%	-2.31%	60.00%	-3.08%	-12.23%	-0.76%	-52.50%	-37.04%	13.48%	-10.40%	70.42%	13.95%	43.56%	18.44%	-24.44%	21.91%	5.44%	9.09%	12.12%	0.87%	25.11%	3.95%	22.68%	-7.41%	-6.84%	1.21%	-13.33%	5.00%	-2.29%	-14.41%	-6.82%	-26.32%	46.88%	-
Timing	-	After-hours	-	-	-	After-hours	Pre-market	Pre-market	-	-	After-hours	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market

Key Statistics & Ratios

Market Cap15.27B

Enterprise Value17.17B

Trailing P/E90.65

Forward P/E14.64

PEG Ratio1.88

Price / Sales1.97

Price / Book2.69

EPS1.69

Book Value56.09

Revenue (TTM)7.75B

Gross Profit (TTM)4.96B

EBITDA1.62B

Profit Margin2.18%

Operating Margin15.94%

Return on Equity2.76%

Return on Assets7.42%

Shares Outstanding99.64M

Shares Float79.84M

Beta0.57

Dividend Yield3.15%

Dividend Rate4.75

Payout Ratio61.13%

Dividends

20261×

4.75Apr 17, 2026

20251×

4.25Apr 11, 2025

20241×

3.75Apr 12, 2024

20231×

3.25Apr 19, 2023

20221×

2.75Apr 8, 2022

20211×

2.50Apr 15, 2021

20201×

2.30Jun 16, 2020

20191×

2.25Apr 12, 2019

20181×

2.00Apr 13, 2018

20171×

1.75Apr 21, 2017

20161×

1.50Apr 14, 2016

20151×

1.25Apr 16, 2015

20141×

1.10Apr 24, 2014

20131×

1.00Apr 16, 2013